← 產業報告目錄

Pharmaceutical Inspection Machines Market by Component (Vision Inspection, X-Ray, Checkweigher, Metal Detector, Software), Type (Manual, Automatic), Packaging Type (Syringe, Blister, Bottle), and Formulation (Parenteral, Oral) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-06-11頁數 355報告編號 PH4491

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The pharmaceutical inspection machines market is projected to reach USD 1.62 billion by 2031 from USD 1.14 billion in 2026, growing at a CAGR of 7.2%. The rapid growth of the ampoules and vials segment is driven by increasing production of injectable drugs, biologics, vaccines, and sterile pharmaceutical products that require stringent quality control and inspection standards. These packaging formats are highly sensitive and demand advanced inspection technologies capable of detecting particulate contamination, cosmetic defects, fill-level inconsistencies, cracks, and seal integrity issues. AI-enabled inspection systems integrated with machine vision and high-resolution imaging technologies provide accurate real-time analysis and improve defect detection capabilities. Rising demand for parenteral formulations, coupled with stricter regulatory requirements and increasing adoption of automated pharmaceutical manufacturing, is accelerating the deployment of advanced inspection systems for ampoules and vials. Additionally, manufacturers are increasingly investing in high-speed inspection solutions to enhance operational efficiency, minimize recalls, and ensure product safety. Based on Component: One of the key factors driving the growth of the software and vision system segment in the Pharmaceutical Inspection Machine market is the increasing adoption of advanced machine vision, AI, and sensor technologies. Inspection systems comprise components such as cameras, sensors, robotics, conveyors, software platforms, and data analytics tools that work together to ensure accurate detection and quality assurance. High-performance imaging systems and AI-enabled software improve the identification of particulate contamination, cosmetic defects, fill-level variations, and packaging inconsistencies with greater precision. In addition, advanced software solutions reduce false rejection rates and support real-time monitoring and process optimization. As pharmaceutical manufacturers continue investing in automation and quality compliance, demand for intelligent inspection components is increasing, strengthening their role in modern pharmaceutical manufacturing environments. Based on Formulation: One of the major factors driving the dominance of injectable and sterile formulation segments in the Pharmaceutical Inspection Machine market is the critical need for stringent quality control and patient safety. Pharmaceutical inspection machines are extensively used for formulations such as injectables, biologics, tablets, capsules, ophthalmic products, and liquid formulations to detect defects, particulate contamination, fill-level inconsistencies, and packaging errors. Injectable and sterile products require highly precise inspection due to strict regulatory requirements and the high risk associated with contamination. In addition, the growing production of biologics, prefilled syringes, and complex drug formulations has increased demand for advanced inspection systems. As pharmaceutical manufacturers continue to prioritize product integrity and compliance, inspection requirements across diverse formulation types are driving sustained market growth. North America’s well-established pharmaceutical manufacturing ecosystem plays a crucial role in driving the adoption of pharmaceutical inspection machines. The region has a strong presence of leading pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and advanced production facilities that require stringent quality control and regulatory compliance. Pharmaceutical manufacturers in the U.S. and Canada increasingly invest in automated inspection technologies, machine vision systems, and AI-enabled quality assurance solutions to enhance operational efficiency and ensure product safety. Additionally, strict regulatory frameworks and quality standards encourage the deployment of advanced inspection systems across production lines. The presence of strong R&D capabilities, high healthcare expenditure, and continuous investments in manufacturing modernization further support market growth. This robust pharmaceutical ecosystem ensures sustained demand and widespread adoption of pharmaceutical inspection machines across the region. A breakdown of the primary participants (supply-side) for the pharmaceutical inspection machine market referred to in this report is provided below: • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C-level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Prominent players in the pharmaceutical inspection machine market are market Körber AG (Germany), Mettler Toledo (US), Omron Corporation (Japan), Cognex Corporation (US), Stevanato Group (Italy), Antares Vision S.p.A. (Italy), Optel Group (Canada), Syntegon Technology GmbH (Germany), Jekson Vision (India), ACG (India), Brevetti CEA S.p.A. (Italy), Roquette Frères (France), Toflon Life Science (China), Prodieco (Ireland), WIPOTEC GmbH (Germany), CMP Pharma S.R.L. (Italy), Keyence Corporation (Japan), Cassel Messtechnik GmbH (Germany), Thermo Fisher Scientific Inc. (US), Loma Systems (UK), VITRONIC Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany), Minebea Intec GmbH (Germany), Marchesini Group S.p.A. (Italy), N.K.P. Pharma Pvt. Ltd. (India), and Span Systems (India). Research Coverage The report evaluates the pharmaceutical inspection machine market and estimates the market size and future growth potential of this market based on various segments, including by component, type, packaging type, formulation, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall, the pharmaceutical inspection machine market, and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market. This report provides insights into the following points: • Analysis of key drivers (increasing adoption of AI- and machine vision-based inspection systems, rising pharmaceutical manufacturing output, growing emphasis on stringent regulatory compliance and quality assurance, rising demand for automated inspection solutions, increasing focus on patient safety and defect reduction), restraints (high implementation and maintenance costs of advanced inspection systems, complex integration with existing manufacturing infrastructure), opportunities (growing adoption of Industry 4.0 and smart manufacturing, rising demand for pharmaceutical inspection solutions in emerging markets), and challenges (shortage of skilled professionals for operating advanced systems, managing high inspection accuracy while minimizing false rejection rates) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global pharmaceutical inspection machines market • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global pharmaceutical inspection machines market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global pharmaceutical inspection machines market
目錄 Table of Contents
1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 STUDY SCOPE 33 1.3.1 SEGMENTS COVERED & REGIONAL SCOPE 33 1.3.2 INCLUSIONS & EXCLUSIONS 34 1.3.3 YEARS CONSIDERED 34 1.3.4 CURRENCY CONSIDERED 35 1.4 STAKEHOLDERS 35 1.5 LIMITATIONS 35 1.6 SUMMARY OF CHANGES 36 2 EXECUTIVE SUMMARY 37 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 37 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 39 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 40 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42 3 PREMIUM INSIGHTS 43 3.1 PHARMACEUTICAL INSPECTION MACHINES MARKET OVERVIEW 43 3.2 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PRODUCT AND COUNTRY (2025) 44 3.3 PHARMACEUTICAL INSPECTION MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45 3.4 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION (2023–2030) 45 3.5 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 46 4 MARKET OVERVIEW 47 4.1 INTRODUCTION 47 4.2 MARKET DYNAMICS 47 4.2.1 DRIVERS 48 4.2.1.1 Increasing use of inspection machines by pharmaceutical and biotechnology companies 48 4.2.1.2 Rising number of inspection checkpoint mandates 49 4.2.1.3 Technological advancements and stringent regulatory mandates for high-quality products 49   4.2.2 RESTRAINTS 50 4.2.2.1 High initial capital expenditure and recurring maintenance costs 50 4.2.2.2 Increased data security and privacy concerns 50 4.2.3 OPPORTUNITIES 51 4.2.3.1 Increasing outsourcing of manufacturing operations to emerging economies 51 4.2.3.2 Focus on production optimization and high R&D investments 52 4.2.4 CHALLENGES 53 4.2.4.1 Complexities in integrating pharmaceutical inspection machines 53 4.3 UNMET NEEDS & WHITE SPACES 53 4.3.1 UNMET NEEDS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 53 4.3.2 WHITE SPACE OPPORTUNITIES 54 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 56 5 INDUSTRY TRENDS 57 5.1 PORTER’S FIVE FORCES ANALYSIS 57 5.1.1 THREAT OF NEW ENTRANTS 58 5.1.2 THREAT OF SUBSTITUTES 58 5.1.3 BARGAINING POWER OF BUYERS 58 5.1.4 BARGAINING POWER OF SUPPLIERS 58 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58 5.2 MACROECONOMIC INDICATORS 59 5.2.1 INTRODUCTION 59 5.2.2 GDP TRENDS & FORECAST 59 5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL INDUSTRY 60 5.2.4 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 61 5.3 SUPPLY CHAIN ANALYSIS 61 5.3.1 ROLE IN SUPPLY CHAIN 63 5.4 VALUE CHAIN ANALYSIS 64 5.5 ECOSYSTEM ANALYSIS 65 5.5.1 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS 66 5.5.2 END USERS 66 5.6 PRICING ANALYSIS 67 5.6.1 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY PRODUCT 68 5.6.2 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY REGION 69 5.6.3 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY END-USE INDUSTRY 69   5.7 TRADE ANALYSIS 69 5.7.1 IMPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 69 5.7.2 EXPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 70 5.7.3 IMPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190) 70 5.7.4 EXPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190) 71 5.8 KEY CONFERENCES & EVENTS, 2026–2027 72 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 5.10 INVESTMENT & FUNDING SCENARIO 73 5.11 CASE STUDY ANALYSIS 74 5.12 IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL INSPECTION MACHINES MARKET 76 5.12.1 INTRODUCTION 76 5.12.2 KEY TARIFF RATES 77 5.12.3 PRICE IMPACT ANALYSIS 78 5.12.4 IMPACT ON COUTRY/REGION 79 5.12.5 IMPACT ON END USE INDUSTRIES 81 5.12.5.1 Pharmaceutical companies 81 5.12.5.2 Biotechnology companies 81 5.12.5.3 Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) 81 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 82 6.1 TECHNOLOGY ANALYSIS 82 6.1.1 KEY EMERGING TECHNOLOGIES 82 6.1.1.1 Machine vision technology 82 6.1.2 COMPLEMENTARY TECHNOLOGIES 83 6.1.2.1 Advanced sensors & imaging techniques 83 6.1.3 TECHNOLOGY/PRODUCT ROADMAP 83 6.2 PATENT ANALYSIS 85 6.2.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR PHARMACEUTICAL INSPECTION SYSTEMS, JANUARY 2015–APRIL 2026 85 6.2.2 LIST OF MAJOR PATENTS, 2023–2026 87 6.3 FUTURE APPLICATIONS 88 6.3.1 AI-POWERED VISUAL DEFECT DETECTION 88 6.3.2 ADVANCED HYPERSPECTRAL & MULTI-IMAGING INSPECTION 88 6.3.3 SMART SENSOR-INTEGRATED INSPECTION SYSTEMS 88 6.3.4 INTEGRATED MULTI-FUNCTION PHARMACEUTICAL INSPECTION PLATFORMS 89 6.4 IMPACT OF AI ON PHARMACEUTICAL INSPECTION MACHINES MARKET 89 6.4.1 TOP USE CASES & MARKET POTENTIAL 90 6.4.2 BEST PRACTICES IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90 6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL INSPECTION MACHINES MARKET 91 6.4.4 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 92 6.4.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL INSPECTION MACHINES MARKET 93 7 SUSTAINABILITY & REGULATORY LANDSCAPE 94 7.1 REGIONAL REGULATIONS & COMPLIANCE 94 7.1.1 REGULATORY ANALYSIS 94 7.1.1.1 North America 94 7.1.1.2 Europe 94 7.1.1.3 APAC 95 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 7.2 INDUSTRY STANDARDS 98 7.2.1 PHARMACEUTICAL INSPECTION MACHINE PRACTICE STANDARDS 98 7.2.2 ELECTRICAL AND MACHINERY SAFETY STANDARD – ISO 12100 & EN 60204-1 98 7.2.3 SOFTWARE LIFECYCLE STANDARD – GAMP 5 & FDA 21 CFR PART 11 98 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 99 8.1 DECISION-MAKING PROCESS 99 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 99 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 99 8.2.2 KEY BUYING CRITERIA 101 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 101 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 102 8.5 MARKET PROFITABILITY 102 8.5.1 REVENUE POTENTIAL 103 8.5.2 COST DYNAMICS 103 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 103 9 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT 105 9.1 INTRODUCTION 106 9.2 PHARMACEUTICAL INSPECTION SYSTEMS 106 9.2.1 VISION INSPECTION SYSTEMS 108 9.2.1.1 Multifunctional vision inspection systems 111 9.2.1.1.1 Versatility and improved production efficiency to drive segmental growth 111   9.2.1.2 Specialized vision inspection systems 112 9.2.1.2.1 Stringent quality standards and better patient well-being to propel segment growth 112 9.2.2 X-RAY INSPECTION SYSTEMS 113 9.2.2.1 Increasing demand for precise underfill and overfill inspection to aid market growth 113 9.2.3 LEAK DETECTION SYSTEMS 116 9.2.3.1 Rising adoption in pharmaceutical applications to drive market growth 116 9.2.4 METAL DETECTORS 118 9.2.4.1 Growing need for metal contaminant detection in food & beverage industry to boost demand 118 9.2.5 CHECKWEIGHERS 120 9.2.5.1 Increased focus on reducing waste in manufacturing process to aid market growth 120 9.2.6 COMBINATION SYSTEMS 122 9.2.6.1 Technological advancements for ensuring thorough quality assessment and regulatory compliance to drive market 122 9.2.7 OTHER PHARMACEUTICAL INSPECTION SYSTEMS 124 9.3 PHARMACEUTICAL INSPECTION SOFTWARE 125 9.3.1 RISING NEED TO IMPROVE INSPECTION EFFICIENCY TO PROPEL ADOPTION 125 10 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE 128 10.1 INTRODUCTION 129 10.2 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES 129 10.2.1 SUPERIOR THROUGHPUT RATES AND DEFECT DETECTION ACCURACY IN HIGH-VISCOSITY SUSPENSIONS TO DRIVE MARKET 129 10.3 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES 131 10.3.1 SIMULTANEOUS INSPECTION CAPABILITIES WITH HIGH STANDARDS OF PHARMACEUTICAL QUALITY CONTROL TO AID MARKET GROWTH 131 10.4 MANUAL PHARMACEUTICAL INSPECTION MACHINES 133 10.4.1 COST-EFFECTIVENESS TO AUGMENT SEGMENT GROWTH 133 11 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE 135 11.1 INTRODUCTION 136 11.2 AMPOULES & VIALS 136 11.2.1 INCREASING DEMAND FOR VACCINES AND BIOPHARMACEUTICALS TO FUEL MARKET GROWTH 136 11.3 SYRINGES 138 11.3.1 IMPROVED SAFETY AND INCREASED COMPLIANCE WITH CGMP STANDARDS TO SUPPORT MARKET GROWTH 138 11.4 BOTTLES 139 11.4.1 RISING DEMAND FOR LIQUID OR SOLID RESIDUE DETECTION TO AUGMENT MARKET GROWTH 139   11.5 BLISTERS 141 11.5.1 SUPERIOR PRODUCT PROTECTION AND ENHANCED PATIENT COMPLIANCE TO BOOST MARKET GROWTH 141 11.6 OTHER PACKAGING TYPES 142 12 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION 144 12.1 INTRODUCTION 145 12.2 ORAL FORMULATIONS 145 12.2.1 TABLETS & CAPSULES 147 12.2.1.1 Increasing applications in pharmaceutical industry to drive segment 147 12.2.2 ORAL SOLUTIONS & SUSPENSIONS/SYRUPS 148 12.2.2.1 Focus on improved product quality and prevention of contamination to fuel segment growth 148 12.2.3 OTHER ORAL FORMULATIONS 149 12.3 PARENTERAL FORMULATIONS 151 12.3.1 INCREASED PRODUCTION THROUGHPUT AND REDUCED HUMAN ERRORS TO BOOST SEGMENT GROWTH 151 12.4 OTHER FORMULATIONS 152 13 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER 154 13.1 INTRODUCTION 155 13.2 PHARMACEUTICAL COMPANIES 155 13.2.1 HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 155 13.3 BIOTECHNOLOGY COMPANIES 157 13.3.1 FOCUS ON REDUCING COUNTERFEIT DRUG PRODUCTION AND IMPROVING PRODUCT QUALITY TO SPUR MARKET GROWTH 157 13.4 CROS & CDMOS 159 13.4.1 LOW MANUFACTURING COSTS AND HIGH-QUALITY MAINTENANCE TO FUEL MARKET GROWTH 159 14 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION 161 14.1 INTRODUCTION 162 14.2 NORTH AMERICA 162 14.2.1 US 168 14.2.1.1 US to dominate North American pharmaceutical inspection machines market during forecast period 168 14.2.2 CANADA 172 14.2.2.1 Focus on better healthcare quality and increased patient safety to support market growth 172 14.3 EUROPE 176 14.3.1 GERMANY 180 14.3.1.1 High healthcare spending and presence of key pharmaceutical manufacturers to aid market growth 180   14.3.2 UK 184 14.3.2.1 Rising demand for personalized medicines and increasing geriatric population to augment market growth 184 14.3.3 FRANCE 188 14.3.3.1 Growth in generic drug market and increased pharmaceutical exports to spur adoption 188 14.3.4 ITALY 192 14.3.4.1 Favorable government initiatives and increased private investments to drive market 192 14.3.5 SPAIN 196 14.3.5.1 Improved healthcare infrastructure and high prevalence of chronic diseases to boost market growth 196 14.3.6 REST OF EUROPE 200 14.4 ASIA PACIFIC 204 14.4.1 CHINA 209 14.4.1.1 Increased investment in healthcare infrastructure to propel market growth 209 14.4.2 JAPAN 213 14.4.2.1 Well-developed pharmaceutical manufacturing industry and stringent healthcare regulations to drive market 213 14.4.3 INDIA 217 14.4.3.1 Growing focus on cost-effective branded drug production to fuel market growth 217 14.4.4 AUSTRALIA 221 14.4.4.1 High R&D expenditure and technological advancements to fuel market growth 221 14.4.5 SOUTH KOREA 225 14.4.5.1 Attractive medical tourism industry and favorable government policies to propel market growth 225 14.4.6 REST OF ASIA PACIFIC 229 14.5 LATIN AMERICA 233 14.5.1 BRAZIL 237 14.5.1.1 Increasing geriatric population and rising per capita income to aid market growth 237 14.5.2 MEXICO 241 14.5.2.1 Improving healthcare infrastructure and burgeoning pharmaceutical industry to augment market growth 241 14.5.3 REST OF LATIN AMERICA 245 14.6 MIDDLE EAST & AFRICA 249 14.6.1 GCC COUNTRIES 252 14.6.1.1 Robust economic growth and high public healthcare spending to support market growth 252   15 COMPETITIVE LANDSCAPE 257 15.1 OVERVIEW 257 15.2 KEY PLAYER STRATEGY/RIGHT TO WIN 257 15.3 REVENUE ANALYSIS, 2023–2025 259 15.4 MARKET SHARE ANALYSIS, 2025 260 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 262 15.5.1 STARS 262 15.5.2 EMERGING LEADERS 262 15.5.3 PERVASIVE PLAYERS 262 15.5.4 PARTICIPANTS 262 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 264 15.5.5.1 Company footprint 264 15.5.5.2 Region footprint 265 15.5.5.3 Component footprint 265 15.5.5.4 Type footprint 266 15.5.5.5 Packaging type footprint 267 15.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 267 15.6.1 PROGRESSIVE COMPANIES 267 15.6.2 RESPONSIVE COMPANIES 267 15.6.3 DYNAMIC COMPANIES 268 15.6.4 STARTING BLOCKS 268 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 269 15.6.5.1 Detailed list of key startups/SMEs 269 15.6.5.2 Competitive benchmarking of key startups/SMEs 269 15.7 COMPANY VALUATION & FINANCIAL METRICS 270 15.7.1 FINANCIAL METRICS 270 15.7.2 COMPANY VALUATION 270 15.8 BRAND/PRODUCT COMPARISON 271 15.9 COMPETITIVE SCENARIO 272 15.9.1 PRODUCT LAUNCHES 272 15.9.2 DEALS 273 15.9.3 EXPANSIONS 274 15.9.4 OTHER DEVELOPMENTS 274 16 COMPANY PROFILES 275 16.1 KEY PLAYERS 275 16.1.1 KÖRBER AG 275 16.1.1.1 Business overview 275 16.1.1.2 Products offered 276 16.1.1.3 Recent developments 278 16.1.1.3.1 Product launches 278 16.1.1.3.2 Deals 278 16.1.1.4 MnM view 279 16.1.1.4.1 Right to win 279 16.1.1.4.2 Strategic choices 279 16.1.1.4.3 Weaknesses & competitive threats 279 16.1.2 METTLER-TOLEDO 280 16.1.2.1 Business overview 280 16.1.2.2 Products offered 281 16.1.2.3 Recent developments 284 16.1.2.3.1 Product launches 284 16.1.2.4 MnM view 285 16.1.2.4.1 Right to win 285 16.1.2.4.2 Strategic choices 285 16.1.2.4.3 Weaknesses & competitive threats 285 16.1.3 OMRON CORPORATION 286 16.1.3.1 Business overview 286 16.1.3.2 Products offered 287 16.1.3.3 Recent developments 288 16.1.3.3.1 Product launches & upgrades 288 16.1.3.3.2 Deals 289 16.1.3.4 MnM view 289 16.1.3.4.1 Right to win 289 16.1.3.4.2 Strategic choices 290 16.1.3.4.3 Weaknesses & competitive threats 290 16.1.4 STEVANATO GROUP 291 16.1.4.1 Business overview 291 16.1.4.2 Products offered 292 16.1.4.3 Recent developments 293 16.1.4.3.1 Product launches & upgrades 293 16.1.4.3.2 Deals 294 16.1.4.4 MnM view 294 16.1.4.4.1 Right to win 294 16.1.4.4.2 Strategic choices 294 16.1.4.4.3 Weaknesses & competitive threats 294 16.1.5 COGNEX CORPORATION 295 16.1.5.1 Business overview 295 16.1.5.2 Products offered 296 16.1.5.3 Recent developments 297 16.1.5.3.1 Product launches 297 16.1.5.3.2 Deals 297 16.1.5.4 MnM view 298 16.1.5.4.1 Right to win 298 16.1.5.4.2 Strategic choices 298 16.1.5.4.3 Weaknesses & competitive threats 298 16.1.6 ANTARES VISION GROUP 299 16.1.6.1 Business overview 299 16.1.6.2 Products offered 300 16.1.6.3 Recent developments 302 16.1.6.3.1 Product launches & upgrades 302 16.1.6.3.2 Deals 303 16.1.6.3.3 Expansion 304 16.1.6.3.4 Other developments 304 16.1.7 OPTEL GROUP 305 16.1.7.1 Business overview 305 16.1.7.2 Products offered 305 16.1.8 SYNTEGON TECHNOLOGY GMBH 307 16.1.8.1 Business overview 307 16.1.8.2 Products offered 307 16.1.8.3 Recent developments 309 16.1.8.3.1 Product launches 309 16.1.9 JEKSON VISION 310 16.1.9.1 Business overview 310 16.1.9.2 Products offered 310 16.1.10 ACG 312 16.1.10.1 Business overview 312 16.1.10.2 Products offered 312 16.1.11 BREVETTI CEA SPA 314 16.1.11.1 Business overview 314 16.1.11.2 Products offered 314 16.1.11.3 Recent developments 316 16.1.11.3.1 Deals 316 16.1.12 ROQUETTE FRÈRES 317 16.1.12.1 Business overview 317 16.1.12.2 Products offered 317 16.1.13 TOFFLON LIFE SCIENCE 319 16.1.13.1 Business overview 319 16.1.13.2 Products offered 319 16.1.14 PRODITEC 320 16.1.14.1 Business overview 320 16.1.14.2 Products offered 320 16.1.15 WIPOTEC GMBH 322 16.1.15.1 Business overview 322 16.1.15.2 Products offered 322   16.1.16 CMP PHARMA S.R.L. 324 16.1.16.1 Business overview 324 16.1.16.2 Products offered 324 16.1.16.3 Recent developments 326 16.1.16.3.1 Expansions 326 16.2 OTHER PLAYERS 327 16.2.1 KEYENCE CORPORATION 327 16.2.2 CASSEL MESSTECHNIK GMBH 328 16.2.3 THERMO FISHER SCIENTIFIC INC. 329 16.2.4 LOMA SYSTEMS 330 16.2.5 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH 330 16.2.6 MINEBEA INTEC GMBH 331 16.2.7 MARCHESINI GROUP S.P.A. 332 16.2.8 N.K.P. PHARMA PVT. LTD. 333 16.2.9 SPAN SYSTEMS 333 17 RESEARCH METHODOLOGY 334 17.1 RESEARCH DATA 334 17.1.1 SECONDARY DATA 334 17.1.1.1 Key data from secondary sources 336 17.1.2 PRIMARY DATA 337 17.1.2.1 Key data from primary sources 338 17.1.2.2 Key industry insights 338 17.2 MARKET SIZE ESTIMATION 339 17.3 MARKET BREAKDOWN & DATA TRIANGULATION 345 17.4 MARKET RANKING ANALYSIS 346 17.5 STUDY ASSUMPTIONS 346 17.6 RISK ASSESSMENT 346 17.7 LIMITATIONS 346 17.7.1 METHODOLOGY-RELATED LIMITATIONS 346 18 APPENDIX 347 18.1 DISCUSSION GUIDE 347 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351 18.3 CUSTOMIZATION OPTIONS 353 18.4 RELATED REPORTS 353 18.5 AUTHOR DETAILS 354
圖表清單 List of Tables & Figures
TABLE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET: INCLUSIONS & EXCLUSIONS 34 TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 35 TABLE 3 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55 TABLE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS 57 TABLE 5 GDP CHANGE, BY KEY COUNTRY, 2023–2030 (USD BILLION) 59 TABLE 6 PHARMACEUTICAL INSPECTION MACHINES MARKET: ROLE IN SUPPLY CHAIN 63 TABLE 7 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS: ROLE IN ECOSYSTEM 66 TABLE 8 END USERS: ROLE IN ECOSYSTEM 67 TABLE 9 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY PRODUCT, 2023–2025 68 TABLE 10 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY END-USE INDUSTRY, 2023–2025 69 TABLE 11 IMPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2021–2025 (THOUSAND USD) 70 TABLE 12 EXPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2021–2025 (THOUSAND USD) 70 TABLE 13 IMPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190), 2021–2025 (USD) 71 TABLE 14 EXPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE-903190), 2021–2025 (USD) 71 TABLE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET: KEY CONFERENCES & EVENTS, MAY 2026–DECEMBER 2027 72 TABLE 16 CASE STUDY 1: IMPROVING CATTLE HEALTH & REPRODUCTIVE OUTCOMES WITH HIGH-RESOLUTION ULTRASOUND 74 TABLE 17 CASE STUDY 2: INTEGRATED SERIALIZATION & INSPECTION FOR BIOLOGICS MANUFACTURING 75 TABLE 18 CASE STUDY 3: NON-DESTRUCTIVE CONTAINER CLOSURE INTEGRITY TESTING (CCIT) FOR STERILE PHARMACEUTICALS 75 TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 77 TABLE 20 KEY PRODUCT-RELATED TARIFFS 77 TABLE 21 CANADA: IMPACT DUE TO US TARIFFS 79 TABLE 22 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 79 TABLE 23 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 80 TABLE 24 TECHNOLOGY/PRODUCT ROADMAP FOR PHARMACEUTICAL INSPECTION MACHINES MARKET (2026–2035) 84 TABLE 25 PHARMACEUTICAL INSPECTION MACHINES MARKET: LIST OF MAJOR PATENTS, JANUARY 2023–APRIL 2026 87 TABLE 26 KEY COMPANIES IMPLEMENTING AI IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90 TABLE 27 BEST PRACTICES IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90 TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL INSPECTION MACHINES MARKET 91 TABLE 29 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 92 TABLE 30 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 31 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 32 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 33 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97 TABLE 34 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98 TABLE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 100 TABLE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 101 TABLE 37 PHARMACEUTICAL INSPECTION MACHINES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 102 TABLE 38 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 106 TABLE 39 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 107 TABLE 40 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 108 TABLE 41 LIST OF KEY VISION INSPECTION SYSTEMS AVAILABLE IN MARKET 109 TABLE 42 VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 110 TABLE 43 VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 44 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR VISION INSPECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 111 TABLE 45 MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 112 TABLE 46 SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 47 LIST OF KEY X-RAY INSPECTION SYSTEMS AVAILABLE IN MARKET 114 TABLE 48 X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115 TABLE 49 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR X-RAY INSPECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 115 TABLE 50 LIST OF KEY LEAK DETECTION SYSTEMS AVAILABLE IN MARKET 116 TABLE 51 LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117 TABLE 52 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR LEAK DETECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 117 TABLE 53 LIST OF KEY METAL DETECTORS AVAILABLE IN MARKET 118 TABLE 54 METAL DETECTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 55 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR METAL DETECTORS, BY REGION, 2024–2031 (UNITS) 119 TABLE 56 KEY CHECKWEIGHERS AVAILABLE IN MARKET 120 TABLE 57 CHECKWEIGHERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121 TABLE 58 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR CHECKWEIGHERS, BY REGION, 2024–2031 (UNITS) 122 TABLE 59 KEY COMBINATION SYSTEMS AVAILABLE IN MARKET 123 TABLE 60 COMBINATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 61 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR COMBINATION SYSTEMS, BY REGION, 2024–2031 (UNITS) 124 TABLE 62 OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 63 KEY PHARMACEUTICAL INSPECTION SOFTWARE AVAILABLE IN MARKET 126 TABLE 64 PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 65 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 129 TABLE 66 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 67 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 68 MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 69 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 136 TABLE 70 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 71 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 72 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 73 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 74 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 75 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 145 TABLE 76 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 77 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 78 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR TABLETS & CAPSULES, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 79 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL SOLUTIONS & SUSPENSIONS/SYRUPS, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 80 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 81 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 82 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 83 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 155 TABLE 84 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 85 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 86 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 87 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 88 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 89 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 164 TABLE 90 NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 91 NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 92 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 93 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 166 TABLE 94 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 167 TABLE 95 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 167 TABLE 96 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 167 TABLE 97 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 168 TABLE 98 US: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 99 US: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 100 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 101 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 170 TABLE 102 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 171 TABLE 103 US: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 171 TABLE 104 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 171 TABLE 105 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 172 TABLE 106 CANADA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 107 CANADA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 108 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 174 TABLE 109 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 174 TABLE 110 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 175 TABLE 111 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 175 TABLE 112 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 113 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 114 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 177 TABLE 115 EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 116 EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 117 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 118 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 178 TABLE 119 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 179 TABLE 120 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 179 TABLE 121 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 179 TABLE 122 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 181 TABLE 123 GERMANY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 181 TABLE 124 GERMANY: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 125 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 182 TABLE 126 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 182 TABLE 127 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 183 TABLE 128 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 183 TABLE 129 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 183 TABLE 130 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 184 TABLE 131 UK: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 132 UK: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185 TABLE 133 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 186 TABLE 134 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 186 TABLE 135 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 187 TABLE 136 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 137 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 187 TABLE 138 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 188 TABLE 139 FRANCE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 140 FRANCE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 141 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 190 TABLE 142 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 190 TABLE 143 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 191 TABLE 144 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 145 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 191 TABLE 146 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 192 TABLE 147 ITALY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 148 ITALY: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 193 TABLE 149 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 194 TABLE 150 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 194 TABLE 151 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 195 TABLE 152 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 153 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 195 TABLE 154 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 196 TABLE 155 SPAIN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 156 SPAIN: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 157 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 198 TABLE 158 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 198 TABLE 159 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 199 TABLE 160 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 199 TABLE 161 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 199 TABLE 162 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 200 TABLE 163 REST OF EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 164 REST OF EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 165 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 166 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 202 TABLE 167 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 203 TABLE 168 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 169 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 203 TABLE 170 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 171 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 206 TABLE 172 ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 173 ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 174 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 175 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 208 TABLE 176 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 208 TABLE 177 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 178 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 209 TABLE 179 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 210 TABLE 180 CHINA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 181 CHINA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 182 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 183 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 211 TABLE 184 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 212 TABLE 185 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 186 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 212 TABLE 187 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 213 TABLE 188 JAPAN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 189 JAPAN: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 190 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 191 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 215 TABLE 192 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 216 TABLE 193 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 194 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 195 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 217 TABLE 196 INDIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 197 INDIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 198 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 199 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 219 TABLE 200 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 220 TABLE 201 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 202 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 203 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 221 TABLE 204 AUSTRALIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 205 AUSTRALIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 206 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 207 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 223 TABLE 208 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 224 TABLE 209 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 210 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 224 TABLE 211 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 225 TABLE 212 SOUTH KOREA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 213 SOUTH KOREA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 214 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227 TABLE 215 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 227 TABLE 216 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 228 TABLE 217 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 218 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 228 TABLE 219 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 229 TABLE 220 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 221 REST OF ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 222 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 223 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 231 TABLE 224 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 232 TABLE 225 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 226 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 232 TABLE 227 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 228 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 233 TABLE 229 LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 230 LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 231 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 232 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 235 TABLE 233 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 236 TABLE 234 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 235 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 236 TABLE 236 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 237 TABLE 237 BRAZIL: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 238 BRAZIL: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 239 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 240 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 239 TABLE 241 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 240 TABLE 242 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 243 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 241 TABLE 244 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 242 TABLE 245 MEXICO: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242 TABLE 246 MEXICO: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 247 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 248 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 243 TABLE 249 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 244 TABLE 250 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 251 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 244 TABLE 252 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 245 TABLE 253 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 254 REST OF LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 255 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 256 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 247 TABLE 257 EST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 248 TABLE 258 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 259 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 248 TABLE 260 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 249 TABLE 261 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 262 MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 263 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 264 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 251 TABLE 265 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 251 TABLE 266 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 252 TABLE 267 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 252 TABLE 268 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 253 TABLE 269 GCC COUNTRIES: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 270 GCC COUNTRIES: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254 TABLE 271 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255 TABLE 272 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 255 TABLE 273 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 256 TABLE 274 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 275 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 256 TABLE 276 KEY DEVELOPMENTS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, JANUARY 2021–MAY 2026 257 TABLE 277 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEGREE OF COMPETITION 260 TABLE 278 PHARMACEUTICAL INSPECTION MACHINES MARKET: REGION FOOTPRINT 265 TABLE 279 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPONENT FOOTPRINT 265 TABLE 280 PHARMACEUTICAL INSPECTION MACHINES MARKET: TYPE FOOTPRINT 266 TABLE 281 PHARMACEUTICAL INSPECTION MACHINES MARKET: PACKAGING TYPE FOOTPRINT 267 TABLE 282 PHARMACEUTICAL INSPECTION MACHINES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 269 TABLE 283 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 269 TABLE 284 PHARMACEUTICAL INSPECTION MACHINES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 272 TABLE 285 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEALS, JANUARY 2022–MAY 2026 273 TABLE 286 PHARMACEUTICAL INSPECTION MACHINES MARKET: EXPANSIONS, JANUARY 2022–MAY 2026 274 TABLE 287 PHARMACEUTICAL INSPECTION MACHINES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2026 274 TABLE 288 KÖRBER AG: COMPANY OVERVIEW 275 TABLE 289 KÖRBER AG: PRODUCTS OFFERED 276 TABLE 290 KÖRBER AG: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 278 TABLE 291 KÖRBER AG: DEALS, JANUARY 2022–MAY 2026 278 TABLE 292 METTLER-TOLEDO: COMPANY OVERVIEW 280 TABLE 293 METTLER-TOLEDO: PRODUCTS OFFERED 281 TABLE 294 METTLER-TOLEDO: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 284 TABLE 295 OMRON CORPORATION: COMPANY OVERVIEW 286 TABLE 296 OMRON CORPORATION: PRODUCTS OFFERED 287 TABLE 297 OMRON CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022–MAY 2026 288 TABLE 298 OMRON CORPORATION: DEALS, JANUARY 2022–MAY 2026 289 TABLE 299 STEVANATO GROUP: COMPANY OVERVIEW 291 TABLE 300 STEVANATO GROUP: PRODUCTS OFFERED 292 TABLE 301 STEVANATO GROUP: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022–MAY 2026 293 TABLE 302 STEVANATO GROUP: DEALS, JANUARY 2022–MAY 2026 294 TABLE 303 COGNEX CORPORATION: COMPANY OVERVIEW 295 TABLE 304 COGNEX CORPORATION: PRODUCTS OFFERED 296 TABLE 305 COGNEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 297 TABLE 306 COGNEX CORPORATION: DEALS, JANUARY 2022–MAY 2026 297 TABLE 307 ANTARES VISION GROUP: COMPANY OVERVIEW 299 TABLE 308 ANTARES VISION GROUP: PRODUCTS OFFERED 300 TABLE 309 ANTARES VISION GROUP: PRODUCT LAUNCHES & UPGRADES, JANUARY 2022–MAY 2026 302 TABLE 310 ANTARES VISION GROUP: DEALS, JANUARY 2022–MAY 2026 303 TABLE 311 ANTARES VISION GROUP: EXPANSION, JANUARY 2022–MAY 2026 304 TABLE 312 ANTARES VISION GROUP: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 304 TABLE 313 OPTEL GROUP: COMPANY OVERVIEW 305 TABLE 314 OPTEL GROUP: PRODUCTS OFFERED 305 TABLE 315 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 307 TABLE 316 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED 307 TABLE 317 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 309 TABLE 318 JEKSON VISION: COMPANY OVERVIEW 310 TABLE 319 JEKSON VISION: PRODUCTS OFFERED 310 TABLE 320 ACG: COMPANY OVERVIEW 312 TABLE 321 ACG: PRODUCTS OFFERED 312 TABLE 322 BREVETTI CEA SPA: COMPANY OVERVIEW 314 TABLE 323 BREVETTI CEA SPA: PRODUCTS OFFERED 314 TABLE 324 BREVETTI CEA SPA: DEALS, JANUARY 2022–MAY 2026 316 TABLE 325 ROQUETTE FRÈRES: COMPANY OVERVIEW 317 TABLE 326 ROQUETTE FRÈRES: PRODUCTS OFFERED 317 TABLE 327 TOFFLON LIFE SCIENCE: COMPANY OVERVIEW 319 TABLE 328 TOFFLON LIFE SCIENCE: PRODUCTS OFFERED 319 TABLE 329 PRODITEC: COMPANY OVERVIEW 320 TABLE 330 PRODITEC: PRODUCTS OFFERED 320 TABLE 331 WIPOTEC GMBH: COMPANY OVERVIEW 322 TABLE 332 WIPOTEC GMBH: PRODUCTS OFFERED 322 TABLE 333 CMP PHARMA S.R.L.: COMPANY OVERVIEW 324 TABLE 334 CMP PHARMA S.R.L.: PRODUCTS OFFERED 324 TABLE 335 CMP PHARMA S.R.L.: EXPANSIONS, JANUARY 2021–MAY 2026 326 TABLE 336 KEYENCE CORPORATION: COMPANY OVERVIEW 327 TABLE 337 CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW 328 TABLE 338 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 329 TABLE 339 LOMA SYSTEMS: COMPANY OVERVIEW 330 TABLE 340 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH: COMPANY OVERVIEW 330   TABLE 341 MINEBEA INTEC GMBH: COMPANY OVERVIEW 331 TABLE 342 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW 332 TABLE 343 N.K.P. PHARMA PVT. LTD.: COMPANY OVERVIEW 333 TABLE 344 SPAN SYSTEMS: COMPANY OVERVIEW 333 FIGURE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET SEGMENTATION & REGIONAL SCOPE 33 FIGURE 2 PHARMACEUTICAL INSPECTION MACHINES MARKET: YEARS CONSIDERED 34 FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 37 FIGURE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET, 2026–2031 38 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 39 FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHARMACEUTICAL INSPECTION MACHINES MARKET 40 FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2026 41 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 42 FIGURE 9 STRINGENT REGULATORY FRAMEWORK IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH 43 FIGURE 10 PHARMACEUTICAL INSPECTION SYSTEMS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2025 44 FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2026 TO 2031 45 FIGURE 12 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2031 45 FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE 46 FIGURE 14 PHARMACEUTICAL INSPECTION MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47 FIGURE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER'S FIVE FORCES ANALYSIS 57 FIGURE 16 PHARMACEUTICAL INSPECTION MACHINES MARKET: SUPPLY CHAIN ANALYSIS 62 FIGURE 17 PHARMACEUTICAL INSPECTION MACHINES MARKET: VALUE CHAIN ANALYSIS 65 FIGURE 18 PHARMACEUTICAL INSPECTION MACHINES MARKET: ECOSYSTEM ANALYSIS 66 FIGURE 19 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY REGION (USD THOUSAND) 69 FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 FIGURE 21 PHARMACEUTICAL INSPECTION MACHINES MARKET: INVESTMENT & FUNDING SCENARIO 74 FIGURE 22 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–DECEMBER 2025) 86 FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL INSPECTION MACHINES (JANUARY 2015–DECEMBER 2025) 87 FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL INSPECTION MACHINE PRODUCTS 100 FIGURE 25 KEY BUYING CRITERIA FOR PHARMACEUTICAL INSPECTION MACHINE PRODUCTS 101 FIGURE 26 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT 163 FIGURE 27 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT 205 FIGURE 28 REVENUE ANALYSIS OF TOP PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2023–2025 (USD MILLION) 259 FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2025 260 FIGURE 30 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 263 FIGURE 31 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY FOOTPRINT 264 FIGURE 32 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 268 FIGURE 33 EV/EBITDA OF KEY VENDORS 270 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 270 FIGURE 35 PHARMACEUTICAL INSPECTION MACHINES MARKET: BRAND/PRODUCT COMPARISON 271 FIGURE 36 KÖRBER AG: COMPANY SNAPSHOT (2025) 276 FIGURE 37 METTLER-TOLEDO: COMPANY SNAPSHOT (2025) 281 FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2025) 287 FIGURE 39 STEVANATO GROUP: COMPANY SNAPSHOT (2025) 292 FIGURE 40 COGNEX CORPORATION: COMPANY SNAPSHOT (2025) 295 FIGURE 41 ANTARES VISION GROUP: COMPANY SNAPSHOT (2025) 300 FIGURE 42 PHARMACEUTICAL INSPECTION MACHINES MARKET: RESEARCH DESIGN 334 FIGURE 43 PRIMARY SOURCES 337 FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 339 FIGURE 45 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE & DEMAND-SIDE PARTICIPANTS 339 FIGURE 46 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 340 FIGURE 47 REVENUE SHARE ANALYSIS ILLUSTRATION: KÖRBER AG 340 FIGURE 48 TOP-DOWN APPROACH 341 FIGURE 49 DEMAND-SIDE MARKET ESTIMATION: PHARMACEUTICAL INSPECTION MACHINE, BY APPLICATION 342 FIGURE 50 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031): IMPACT ON MARKET GROWTH AND CAGR 343 FIGURE 51 CAGR PROJECTIONS 344 FIGURE 52 DATA TRIANGULATION METHODOLOGY 345

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們